Real-world data of IDH mutant gliomas in Spain, a RETSINE: GEINO study

被引：0

作者：

Mazariegos-Rubi, M. A. ^{[1
]}

Girones Sarrio, R. ^{[2
]}

del Barco, S. ^{[3
]}

Garcia Castano, A. ^{[4
]}

Velilla, G. ^{[5
]}

Domenech Vinolas, M. ^{[6
]}

Alonso Garcia, M. ^{[7
]}

Ferreira Freire, L. ^{[8
]}

Luque Caro, N. ^{[9
]}

Fernandez Perez, I. ^{[10
]}

Quintanar Verduguez, T. ^{[11
]}

Peralta Munoz, S. ^{[12
]}

Ceballos Lenza, I. ^{[13
]}

Iza Rodriguez, E. ^{[14
]}

Sanfeliz, C. ^{[15
]}

Pablo Martin, E. ^{[16
]}

Almagro Casado, E. ^{[17
]}

Mazarico, J. M. ^{[18
]}

Esteve, A. ^{[19
]}

Pineda, E. ^{[20
]}

机构：

[1] Hosp Clin Barcelona, Med Oncol Dept, Barcelona, Spain

[2] Hosp La Fe, Oncol, Valencia, Spain

[3] Inst Catala Oncol Girona, Med Oncol Dept, Girona, Spain

[4] HUMV Hosp Univ Marques Valdecilla, Med Oncol Dept, Santander, Spain

[5] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain

[6] Inst Catala Oncol Badalona, Oncol Dept, Badalona, Spain

[7] Hosp Univ Virgen Rocio, Med Oncol Dept, Seville, Spain

[8] Hosp Univ Lucus Augusti HULA, Med Oncol Dept, Lugo, Spain

[9] Complejo Hosp Jaen Univ Jaen, Med Oncol Dept, Jaen, Spain

[10] CHUVI Complejo Hosp Univ Vigo, Oncol Dept, Vigo, Pontevedra, Spain

[11] Hosp Gen Univ Elche, Med Oncol, Elche, Alicante, Spain

[12] Hosp Univ Sant Joan Reus, Med Oncol Dept, Reus, Tarragona, Spain

[13] Hosp Univ Canarias, Oncol Dept, Santa Cruz De Tenerife, Canary Islands, Spain

[14] Hosp Univ Cruces, Oncol Med, Baracaldo, Spain

[15] Hosp Torrecardenas, Med Oncol Dept, Almeria, Spain

[16] Univ Hosp Salamanca, Med Oncol Dept, Salamanca, Spain

[17] Hosp Univ Quironsalud Madrid, Med Oncol Deprtment, Pozuelo De Alarcon, Madrid, Spain

[18] Hosp Mutua Terrassa, Med Oncol Dept, Terrassa, Spain

[19] Hosp Badalona Germans Trias & Pujol, ICO Inst Catala Oncol Badalona, Oncol, Badalona, Spain

[20] Hosp Clin Barcelona, Med Oncol Dept, Barcelona, Spain

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.08.526

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

456P

引用

页码：S412 / S412

页数：1

共 50 条

[1] P25.03.B RWD OF IDH MUTANT GLIOMAS IN SPAIN, A RETSINE - GEINO STUDY
Mazariegos, M.
Girones, R.
Del Barco, S.
Garcia, A.
Velilla, G.
Hernandez, A.
Alonso, M.
Ferreira, L.
Luque, N.
Fernandez, I
Quintanar, T.
Peralta, S.
Ceballos, I
Iza, E.
Sanchez, M.
Martin, E. Pablo
Casado, E. Almagro
Mazarico, J.
Duran, G.
Alvarez, P.
Ayala, P.
Gallego, O.
Sarabia, R.
de las Penas, R.
Nunez, I
Morilla, I
Cunquero, A.
Cheverria, N.
Moya, I
Vaz, M.
Luque, R.
Esteve, A.
Pineda, E.
NEURO-ONCOLOGY, 2024, 26 : V131 - V131
[2] REAL-WORLD ASSESSMENT OF IDH1 INHIBITOR IVOSIDENIB IN IDH MUTANT LOWER GRADE GLIOMAS - THE JOHNS HOPKINS EXPERIENCE
Puri, Sushant
Shi, Jessica
Blair, Lindsay
Blakeley, Jaishri
Laterra, John
Kamson, David
NEURO-ONCOLOGY, 2022, 24 : 181 - 181
[3] Real-World Outcomes of IDH Mutant AML Patients Treated with or without IDH Inhibitors
Al Sbihi, Ali
Reddy, Sushmitha Nanja
Dhillon, Vikram
Lalo, Enxhi
Ramos, Harry
Khan, Abdul Moiz
Balasubramanian, Suresh Kumar
BLOOD, 2022, 140 : 6189 - 6190
[4] Real-world study: from real-world data to real-world evidence
Wen, Yi
TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
[5] Multi-center real-world data-driven web calculator for predicting outcomes in IDH-mutant gliomas: Integrating molecular subtypes and treatment modalities
Xu, Houshi
Liu, Beining
Wang, Yue
Zhu, Ruize
Jiang, Shan
Soliman, Lina Akmal Fouad Abdelhamid
Chai, Huihui
Sun, Maoyuan
Chen, Jiawen
Li, Kay Ka-Wai
Ng, Ho-Keung
Zhang, Zhenyu
Wei, Junji
Shi, Zhifeng
Mao, Ying
NEURO-ONCOLOGY ADVANCES, 2025, 7 (01)
[6] Determination of essential biomarkers in lung cancer: A real-world data study in Spain
Calvo de Juan, V.
Cobo Dols, M.
Rodriguez-Abreu, D.
Carcereny, E.
Cantero, A.
Bernabe Caro, R.
Benitez Lopez, G.
Lopez Castro, R.
Massuti Sureda, B.
del Barco, E.
Garcia Campelo, M. R.
Guirado, M.
Camps Herrero, C. J. C.
Ortega Granados, A. L. O.
Gonzalez-Larriba, J. L.
Sanchez Hernandez, A.
Gonzalez Ojea, C.
Sala Gonzalez, M. A.
Juan Vidal, O. J.
Provencio Pulla, M.
ANNALS OF ONCOLOGY, 2022, 33 : S50 - S50
[7] REAL-WORLD OUTCOMES AMONG HIGH GRADE IDH1-MUTANT GLIOMA PATIENTS TREATED WITH AN IDH INHIBITOR
Ziv, Michal Nisnboym
Patel, Mallika P.
Minor, Maria
Johnson, Margaret O.
Batich, Kristen
Low, Justin
Shoaf, Madison L.
Khasraw, Mustafa
Desjardins, Annick
Friedman, Henry S.
Ashley, David M.
Peters, Katherine B.
NEURO-ONCOLOGY, 2024, 26
[8] Real-World Battles with Real-World Data
Brown, Jeffrey
Bate, Andrew
Platt, Robert
Raebel, Marsha
Sauer, Brian
Trifiro, Gianluca
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 254 - 255
[9] Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain
Patricia Pozo-Rosich
Mafalda Carmo
Alejandro Muñiz
Beatriz Armada
Carlota Moya-Alarcón
Julio Pascual
BMC Neurology, 24
[10] Translating real-world evidence/real-world data
Ravenstijn, Paulien
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):

← 1 2 3 4 5 →